{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:00:30Z","timestamp":1778853630258,"version":"3.51.4"},"reference-count":42,"publisher":"Informa UK Limited","issue":"18","funder":[{"name":"WACCBIP-World Bank ACE PhD fellowship","award":["ACE02-WACCBIP"],"award-info":[{"award-number":["ACE02-WACCBIP"]}]},{"name":"DELTAS Africa","award":["DEL-15-007"],"award-info":[{"award-number":["DEL-15-007"]}]},{"DOI":"10.13039\/501100011858","name":"African Academy of Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Welcome Trust","doi-asserted-by":"crossref","award":["107755\/Z15\/Z"],"award-info":[{"award-number":["107755\/Z15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.2217\/fmb-2020-0179","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T15:29:54Z","timestamp":1609946994000},"page":"1691-1695","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Parallels in the Pathogenesis of SARS-CoV-2 and\n            <i>M. Tuberculosis<\/i>\n            : a synergistic or Antagonistic Alliance?"],"prefix":"10.1080","volume":"15","author":[{"given":"Kesego","family":"Tapela","sequence":"first","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP),University of Ghana,\rAccra,\rGhana"},{"name":"Department of Biochemistry,Cell &amp; Molecular Biology,College of Basic &amp; Applied Sciences,University of Ghana,\rAccra,\rGhana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1747-2963","authenticated-orcid":false,"given":"Charles","family":"Ochieng\u2019 Olwal","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP),University of Ghana,\rAccra,\rGhana"},{"name":"Department of Biochemistry,Cell &amp; Molecular Biology,College of Basic &amp; Applied Sciences,University of Ghana,\rAccra,\rGhana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0621-876X","authenticated-orcid":false,"given":"Osbourne","family":"Quaye","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP),University of Ghana,\rAccra,\rGhana"},{"name":"Department of Biochemistry,Cell &amp; Molecular Biology,College of Basic &amp; Applied Sciences,University of Ghana,\rAccra,\rGhana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2762"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.45053"},{"issue":"20","key":"e_1_3_2_4_1","first-page":"1","article-title":"Articles Triple combination of interferon beta-1b, lopinavir \u2013 ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, Phase II trial","volume":"6736","author":"Hung IF","year":"2020","unstructured":"Hung IF , LungK , TsoEYet al. Articles Triple combination of interferon beta-1b, lopinavir \u2013 ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, Phase II trial. Lancet6736(20), 1\u201310 (2020).","journal-title":"Lancet"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0407-x"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25748"},{"key":"e_1_3_2_7_1","unstructured":"Demes L . Doctor\u2019 s note: coronavirus and patients with TB and HIV poor socioeconomic conditions (2020). http:\/\/www.aljazeera.com\/features\/2020\/4\/8\/doctors-note-coronavirus-and-patients-with-tb-and-hiv"},{"key":"e_1_3_2_8_1","unstructured":"WHO . Global Tuberculosis Report 2019 New data on tuberculosis trends in 202 countries. http:\/\/www.who.int\/tb\/global-report-2019"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2003138117"},{"issue":"2000607","key":"e_1_3_2_12_1","first-page":"9","article-title":"Pathogenesis of COVID-19 from a cell biology perspective","volume":"55","author":"Mason RJ","year":"2020","unstructured":"Mason RJ . Pathogenesis of COVID-19 from a cell biology perspective. Eur. Respir. J.55(2000607), 9\u201311 (2020).","journal-title":"Eur. Respir. J."},{"key":"e_1_3_2_13_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01312","article-title":"The lung macrophage in SARS-CoV-2 infection: a friend or a foe?","volume":"11","author":"Abassi Z","year":"2020","unstructured":"Abassi Z , KnaneyY , KarramT , HeymanSN. The lung macrophage in SARS-CoV-2 infection: a friend or a foe?Front. Immunol.11(June), 1\u20135 (2020).","journal-title":"Front. Immunol."},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000474"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-016-0185-5"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/179174"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/35085034"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2019.01.011"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0331-4"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2020.05.003"},{"key":"e_1_3_2_21_1","first-page":"0896","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"102452","author":"Liu B","year":"2020","unstructured":"Liu B , LiM , ZhouZ , GuanX , XiangY. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?J. Autoimmun.102452, 0896\u20138411 (2020).","journal-title":"J. Autoimmun."},{"issue":"189","key":"e_1_3_2_22_1","first-page":"1","article-title":"Severe COVID-19: a review of recent progress with a look toward the future","volume":"8","author":"Xie P","year":"2020","unstructured":"Xie P , MaW , TangH , LiuD. Severe COVID-19: a review of recent progress with a look toward the future. Front. Public Health8(189), 1\u20137 (2020).","journal-title":"Front. Public Health"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2014.09.011"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(11)80364-5"},{"issue":"5","key":"e_1_3_2_25_1","first-page":"533","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng M","year":"2020","unstructured":"Zheng M , GaoY , WangGet al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Int. J. Infect. Dis.17(5), 533\u2013535 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.04.086"},{"issue":"1","key":"e_1_3_2_27_1","first-page":"16","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan L","year":"2020","unstructured":"Tan L , WangQ , ZhangDet al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct. Target Ther.5(1), 16\u201318 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783X-16-6-285"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080941"},{"key":"e_1_3_2_30_1","first-page":"PA2667","article-title":"Lymphocytopenia in pulmonary tuberculosis: does it have a clinical value?","volume":"48","author":"Fehri SM","year":"2016","unstructured":"Fehri SM , RacilH , HabibechSet al. Lymphocytopenia in pulmonary tuberculosis: does it have a clinical value? Eur. Respir. J. 48, PA2667 (2016).","journal-title":"Eur. Respir. J."},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2014.09.011"},{"issue":"20","key":"e_1_3_2_32_1","first-page":"1","article-title":"Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort","volume":"3018","author":"Vizcarra P","year":"2020","unstructured":"Vizcarra P , P\u00e9rez-El\u00edasMJ , QueredaCet al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV3018(20), 1\u201311 (2020).","journal-title":"Lancet HIV"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2012.01848.x"},{"key":"e_1_3_2_34_1","first-page":"67","article-title":"The immunopathology of tuberculosis, the mode of action of the Bacillus Calmette\u2013Gu\u00e9rin, of the tuberculin and of the immunotherapy","volume":"3","author":"Roland M","year":"2019","unstructured":"Roland M . The immunopathology of tuberculosis, the mode of action of the Bacillus Calmette\u2013Gu\u00e9rin, of the tuberculin and of the immunotherapy. BBRJ3, 67\u201376 (2019).","journal-title":"BBRJ"},{"key":"e_1_3_2_35_1","unstructured":"WHO . Bacille Calmette-Gu\u00e9rin (BCG) vaccination and COVID-19 (2020). http:\/\/www.who.int\/news-room\/commentaries\/detail\/bacille-calmette-gu\u00e9rin-(bcg)-vaccination-and-covid-19"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.04.020"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1159\/000355628"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1098"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0337-y"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17155589"},{"issue":"17","key":"e_1_3_2_41_1","first-page":"1","article-title":"Correlation between immunity from BCG and the morbidity and mortality of COVID-19","volume":"6","author":"Wickramasinghe D","year":"2020","unstructured":"Wickramasinghe D , WickramasingheN , KamburugamuwaSA , ArambepolaC , SamarasekeraDN. Correlation between immunity from BCG and the morbidity and mortality of COVID-19. Trop. Dis. Travel Med. Vac.6(17), 1\u201315 (2020).","journal-title":"Trop. Dis. Travel Med. Vac."},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0337-y"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb-2020-0179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:40:05Z","timestamp":1719124805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb-2020-0179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":42,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.2217\/fmb-2020-0179"],"URL":"https:\/\/doi.org\/10.2217\/fmb-2020-0179","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}